Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Army
Baxter
Deloitte
Federal Trade Commission
Daiichi Sankyo

Generated: July 21, 2019

DrugPatentWatch Database Preview

Patent: 6,339,160

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,339,160
Title: Metalloproteinase inhibitors, their therapeutic use and process for the production of the starting compound in the synthesis thereof
Abstract:Objects of the present invention are compounds of a peptido-mimetic character having the capacity of acting as inhibitors of metalloproteinases produced by venom of snake, and of other metalloproteinases of human origin which have been put in relation with various pathologies in man, including tumoral growth and metastatization, aterosclerosis, multiple sclerosis, Alzheimer\'s disease, osteoporosis, hypertension, rheumatoid arthritis and other inflammatory diseases. Object of the present invention is also the procedure for the production of diethylester of (1)-phosphotryptophan, as an initial product necessary to synthesize all compounds mentioned above.
Inventor(s): Politi; Vincenzo (Rome, IT), Gavuzzo; Enrico (Rome, IT), Gallina; Carlo (Rome, IT), Stazio; Giovanni Di (Rome, IT), D\'Alessio; Silvana (Rome, IT), Sella; Antonio (Rome, IT), Piazza; Cinzia (Rome, IT), Giordano; Cesare (Rome, IT), Gorini; Barbara (Rome, IT), Panini; Gabriella (Rome, IT), Paradisi; Mario Paglialunga (Rome, IT), Cirilli; Maurizio (Rome, IT), Pochetti; Giorgio (Rome, IT), Mazza; Fernando (Rome, IT)
Assignee: Polifarma S.p.A. (Rome, IT) Consiglio Nazionale Delle Ricerche (Rome, IT)
Application Number:09/462,932
Patent Claims:see list of patent claims

Details for Patent 6,339,160

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04 ➤ Sign Up Polifarma S.p.A. (Rome, IT) Consiglio Nazionale Delle Ricerche (Rome, IT) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Moodys
Deloitte
McKesson
Cipla
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.